HK1044988A1 - Methods for predicting and/or diagnosing the risk of gastric cancer - Google Patents

Methods for predicting and/or diagnosing the risk of gastric cancer

Info

Publication number
HK1044988A1
HK1044988A1 HK02106514.2A HK02106514A HK1044988A1 HK 1044988 A1 HK1044988 A1 HK 1044988A1 HK 02106514 A HK02106514 A HK 02106514A HK 1044988 A1 HK1044988 A1 HK 1044988A1
Authority
HK
Hong Kong
Prior art keywords
diagnosing
predicting
risk
methods
gastric cancer
Prior art date
Application number
HK02106514.2A
Other languages
Chinese (zh)
Inventor
Llewellyn Clancy Robert
Pang Gerald
Original Assignee
Onco Alert Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onco Alert Pty Ltd filed Critical Onco Alert Pty Ltd
Publication of HK1044988A1 publication Critical patent/HK1044988A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
HK02106514.2A 1999-05-14 2002-09-04 Methods for predicting and/or diagnosing the risk of gastric cancer HK1044988A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (1)

Publication Number Publication Date
HK1044988A1 true HK1044988A1 (en) 2002-11-08

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106514.2A HK1044988A1 (en) 1999-05-14 2002-09-04 Methods for predicting and/or diagnosing the risk of gastric cancer

Country Status (10)

Country Link
EP (1) EP1183540A4 (en)
JP (1) JP2002544520A (en)
KR (1) KR20020033093A (en)
CN (1) CN1355885A (en)
AU (1) AUPQ037799A0 (en)
BR (1) BR0010558A (en)
CA (1) CA2372761A1 (en)
HK (1) HK1044988A1 (en)
MX (1) MXPA01011721A (en)
WO (1) WO2000070348A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
KR20140074293A (en) * 2011-09-14 2014-06-17 바스프 에스이 Means and methods for assessing kidney toxicity
JP6707248B2 (en) * 2013-12-05 2020-06-10 学校法人北里研究所 Gastric cancer cell detection method and gastric cancer cell detection kit
RU2706118C1 (en) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Method for prediction of precancer diseases of stomach
CN117143234B (en) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 Monoclonal antibody against rat interleukin-4 protein and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
IT1289578B1 (en) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa IMMUNOPURIFICATION OF AN ANTIGEN WITH AN APPARENT MOLECULAR WEIGHT OF 16 + - 2 KDA OF THE HELICOBACTER PYLORI AND METHODS FOR ITS

Also Published As

Publication number Publication date
CA2372761A1 (en) 2000-11-23
WO2000070348A1 (en) 2000-11-23
KR20020033093A (en) 2002-05-04
JP2002544520A (en) 2002-12-24
AUPQ037799A0 (en) 1999-06-10
BR0010558A (en) 2002-02-19
CN1355885A (en) 2002-06-26
EP1183540A1 (en) 2002-03-06
EP1183540A4 (en) 2007-07-04
MXPA01011721A (en) 2003-09-10

Similar Documents

Publication Publication Date Title
EP1931272A4 (en) Methods and systems for determining physiologic characteristics for treatment of the esophagus
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
IL147683A0 (en) Microarrays and their manufacture
NO992351D0 (en) The method and procedure for installing it
EP1208421A4 (en) Methods for obtaining and using haplotype data
GB0100426D0 (en) Downhole multiplexer and related methods
PT1818343E (en) Antibodies against human il-12
AU3367799A (en) Methodology for predicting and/or diagnosing disease
HK1041025A1 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1465801A (en) Methods for cancer prognosis and diagnosis
EP1175616A4 (en) Methods for the diagnosis and treatment of metastatic prostate tumors
GB2368641B (en) Methods and compositions for assaying analytes
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
AU2002257033A1 (en) Agents and methods for the prevention of initial onset and recurrence of existing cancers
EP1081221A4 (en) Endo-beta-n-acetylglucosaminidase gene
HK1044988A1 (en) Methods for predicting and/or diagnosing the risk of gastric cancer
GB9907687D0 (en) Assays methods and means
ZA200110474B (en) Method and device for the continuous of NaAlCl4 or NaFeCl4.
GB9902662D0 (en) Early entry
GB9812550D0 (en) Tumour therapy and imaging
AU3429300A (en) Means for diagnosing and treating carcinoma
IL159975A0 (en) Stain-directed molecular analysis for cancer prognosis and diagnosis
AU2003294272A8 (en) Methods for diagnosing the presence or stage of cancer
GB0223575D0 (en) Downhole multiplexer and related methods
GB9928789D0 (en) Naive screening method